- NCIt
- C2896
Loading cancer entity…
Loading cancer entity…
Clinical trials
89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07805798 | Urinary Bladder Matrix (UBM) Registry | not yet recruiting | — | 300 | Integra LifeSciences CorporationINDUSTRY | 0 | Sep 4, 2026 | clinicaltrials |
| NCT07301424 | Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL | not yet recruiting | Phase 2 | 80 | University of AlbertaOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer |
| not yet recruiting |
| Phase 1 |
| 18 |
| Jonsson Comprehensive Cancer CenterOTHER |
| 1 |
| Aug 6, 2026 |
| clinicaltrials |
| NCT07543926 | New Treatment of Common Wart | not yet recruiting | N/A | 70 | Sohag UniversityOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT07307534 | Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study | not yet recruiting | N/A | 60 | Xijing HospitalOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06749665 | Sclerotherapy and Candida Antigen in Treatment of Common Warts | not yet recruiting | N/A | 75 | Sohag UniversityOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06661577 | An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions. | not yet recruiting | — | 3,000 | University of Auckland, New ZealandOTHER | 1 | Oct 28, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Sep 4, 2026source: clinicaltrials